Stock Screener
Stock Research
Market Indexes
Precious Metals
Energy
Commodities
Interest Rates
Economy
Global Metrics

Ionis Pharmaceuticals Cash on Hand 2010-2024 | IONS

Ionis Pharmaceuticals cash on hand from 2010 to 2024. Cash on hand can be defined as cash deposits at financial institutions that can immediately be withdrawn at any time, and investments maturing in one year or less that are highly liquid and therefore regarded as cash equivalents and reported with or near cash line items.
  • Ionis Pharmaceuticals cash on hand for the quarter ending December 31, 2024 was $2.298B, a 1.44% decline year-over-year.
  • Ionis Pharmaceuticals cash on hand for 2024 was $2.298B, a 1.44% decline from 2023.
  • Ionis Pharmaceuticals cash on hand for 2023 was $2.331B, a 17.33% increase from 2022.
  • Ionis Pharmaceuticals cash on hand for 2022 was $1.987B, a 6.06% decline from 2021.
  
Ionis Pharmaceuticals Annual Cash on Hand
(Millions of US $)
2024 $2,298
2023 $2,331
2022 $1,987
2021 $2,115
2020 $1,892
2019 $2,500
2018 $2,084
2017 $1,023
2016 $665
2015 $804
2014 $811
2013 $709
2012 $408
2011 $344
2010 $472
2009 $574
Ionis Pharmaceuticals Quarterly Cash on Hand
(Millions of US $)
2024-12-31 $2,298
2024-09-30 $2,483
2024-06-30 $2,079
2024-03-31 $2,206
2023-12-31 $2,331
2023-09-30 $2,236
2023-06-30 $2,385
2023-03-31 $2,347
2022-12-31 $1,987
2022-09-30 $1,982
2022-06-30 $2,022
2022-03-31 $2,052
2021-12-31 $2,115
2021-09-30 $1,987
2021-06-30 $2,059
2021-03-31 $1,820
2020-12-31 $1,892
2020-09-30 $2,329
2020-06-30 $2,349
2020-03-31 $2,384
2019-12-31 $2,500
2019-09-30 $2,221
2019-06-30 $2,262
2019-03-31 $2,254
2018-12-31 $2,084
2018-09-30 $1,959
2018-06-30 $1,980
2018-03-31 $1,035
2017-12-31 $1,023
2017-09-30 $1,011
2017-06-30 $856
2017-03-31 $860
2016-12-31 $665
2016-09-30 $697
2016-06-30 $672
2016-03-31 $724
2015-12-31 $804
2015-09-30 $831
2015-06-30 $816
2015-03-31 $789
2014-12-31 $811
2014-09-30 $639
2014-06-30 $648
2014-03-31 $695
2013-12-31 $709
2013-09-30 $736
2013-06-30 $653
2013-03-31 $417
2012-12-31 $408
2012-09-30 $344
2012-06-30 $336
2012-03-31 $334
2011-12-31 $344
2011-09-30 $365
2011-06-30 $395
2011-03-31 $427
2010-12-31 $472
2010-09-30 $498
2010-06-30 $522
2010-03-31 $519
2009-12-31 $574
2009-09-30 $608
2009-06-30 $638
2009-03-31 $652
Sector Industry Market Cap Revenue
Medical Medical - Drug Manufacturing $5.134B $0.705B
Ionis Pharmaceuticals discovers/develops RNA-targeted therapeutics using its proprietary antisense oligonucleotide technology. Its antisense medicines have been developed/are being developed to treat neurological, cardiovascular and specialty rare diseases.
Stock Name Country Market Cap PE Ratio
Chugai Pharmaceutical (CHGCY) Japan $92.840B 34.83
Zoetis (ZTS) United States $70.908B 26.46
Daiichi Sankyo, - (DSNKY) Japan $46.582B 23.70
Takeda Pharmaceutical (TAK) Japan $45.692B 9.09
Sandoz Group AG (SDZNY) Switzerland $20.090B 0.00
Merck (MKKGY) Germany $17.991B 14.89
Summit Therapeutics (SMMT) United States $17.794B 0.00
Shionogi (SGIOY) Japan $14.019B 14.05
United Therapeutics (UTHR) United States $13.596B 12.03
Neurocrine Biosciences (NBIX) United States $11.451B 39.22
IPSEN (IPSEY) France $9.860B 0.00
Orion OYJ (ORINY) Finland $8.661B 23.42
Corcept Therapeutics (CORT) United States $7.448B 60.54
Stevanato Group S.p.A (STVN) Italy $7.268B 44.44
Madrigal Pharmaceuticals (MDGL) United States $6.542B 0.00
Hikma Pharmaceuticals Plc (HKMPF) United Kingdom $5.976B 0.00
Ono Pharmaceutical (OPHLF) Japan $5.040B 10.32
Grifols, S.A (GRFS) Spain $4.882B 0.00
Soleno Therapeutics (SLNO) United States $3.869B 0.00
Crinetics Pharmaceuticals (CRNX) United States $2.873B 0.00
Catalyst Pharmaceuticals (CPRX) United States $2.850B 9.99
Hypermarcas (HYPMY) Brazil $2.486B 16.35
AMNEAL PHARMACEUTICALS, INC (AMRX) United States $2.297B 12.56
BioCryst Pharmaceuticals (BCRX) United States $2.086B 0.00
NewAmsterdam Pharma (NAMS) Netherlands $2.017B 0.00
Recursion Pharmaceuticals (RXRX) United States $1.741B 0.00
Centessa Pharmaceuticals (CNTA) United Kingdom $1.638B 0.00
Guardian Pharmacy Services (GRDN) United States $1.622B 0.00
Indivior (INDV) United States $1.528B 6.48
Evotec AG (EVO) Germany $1.527B 0.00
ARS Pharmaceuticals (SPRY) United States $1.320B 168.00
Dyne Therapeutics (DYN) United States $1.297B 0.00
Ocular Therapeutix (OCUL) United States $1.125B 0.00
Aurinia Pharmaceuticals Inc (AUPH) Canada $1.093B 44.44
Collegium Pharmaceutical (COLL) United States $0.928B 5.01
Avadel Pharmaceuticals (AVDL) Ireland $0.907B 0.00
Enliven Therapeutics (ELVN) United States $0.904B 0.00
Harrow (HROW) United States $0.895B 0.00
Ardelyx (ARDX) United States $0.866B 0.00
Xeris Biopharma Holdings (XERS) United States $0.783B 0.00
Cronos Group (CRON) Canada $0.763B 0.00
AleAnna (ANNA) United States $0.732B 0.00
Akebia Therapeutics (AKBA) United States $0.668B 0.00
Xencor (XNCR) United States $0.593B 0.00
KalVista Pharmaceuticals (KALV) United States $0.592B 0.00
USANA Health Sciences (USNA) United States $0.549B 11.94
Bioventus (BVS) United States $0.547B 13.92
Regulus Therapeutics (RGLS) United States $0.521B 0.00
Relay Therapeutics (RLAY) United States $0.514B 0.00
CytoDyn (CYDY) United States $0.497B 0.00
Savara (SVRA) United States $0.494B 0.00
Elite Pharmaceuticals (ELTP) United States $0.469B 0.00
Theravance Biopharma (TBPH) Cayman Islands $0.449B 0.00
Altimmune (ALT) United States $0.431B 0.00
Zevra Therapeutics (ZVRA) United States $0.430B 0.00
Amylyx Pharmaceuticals (AMLX) United States $0.411B 0.00
Siga Technologies (SIGA) United States $0.404B 8.45
Organogenesis (ORGO) United States $0.388B 0.00
Tourmaline Bio (TRML) United States $0.388B 0.00
Verve Therapeutics (VERV) United States $0.377B 0.00
Oruka Therapeutics (ORKA) United States $0.357B 0.00
Rigel Pharmaceuticals (RIGL) United States $0.335B 9.07
Heron Therapeutics (HRTX) United States $0.322B 0.00
Aquestive Therapeutics (AQST) United States $0.277B 0.00
Nature's Sunshine Products (NATR) United States $0.253B 23.39
ProKidney (PROK) United States $0.211B 0.00
Wellgistics Health (WGRX) United States $0.195B 0.00
MediWound (MDWD) Israel $0.189B 0.00
Avita Medical (RCEL) United States $0.184B 0.00
OmniAb (OABI) United States $0.176B 0.00
Nanobiotix S.A (NBTX) France $0.161B 0.00
Journey Medical (DERM) United States $0.159B 0.00
Esperion Therapeutics (ESPR) United States $0.158B 0.00
Inhibikase Therapeutics (IKT) United States $0.149B 0.00
Korro Bio (KRRO) United States $0.146B 0.00
4D Molecular Therapeutics (FDMT) United States $0.143B 0.00
Profound Medical (PROF) Canada $0.139B 0.00
Aclaris Therapeutics (ACRS) United States $0.136B 0.00
Larimar Therapeutics (LRMR) United States $0.136B 0.00
Aldeyra Therapeutics (ALDX) United States $0.131B 0.00
Protara Therapeutics (TARA) United States $0.125B 0.00
Innate Pharma SA (IPHYF) France $0.122B 0.00
Tonix Pharmaceuticals Holding (TNXP) United States $0.121B 0.00
Lyell Immunopharma (LYEL) United States $0.118B 0.00
Ironwood Pharmaceuticals (IRWD) United States $0.115B 0.00
Enanta Pharmaceuticals (ENTA) United States $0.112B 0.00
Nektar Therapeutics (NKTR) United States $0.110B 0.00
VAXART, INC (VXRT) United States $0.096B 0.00
OptiNose (OPTN) United States $0.095B 0.00
Cardiol Therapeutics (CRDL) Canada $0.095B 0.00
Lexeo Therapeutics (LXEO) United States $0.089B 0.00
Dominari Holdings (DOMH) United States $0.088B 0.00
Galectin Therapeutics (GALT) United States $0.087B 0.00
Champions Oncology (CSBR) United States $0.086B 14.14
Cassava Sciences (SAVA) United States $0.086B 0.00
Arch Biopartners (ACHFF) Canada $0.082B 0.00
Achieve Life Sciences (ACHV) Canada $0.082B 0.00
Fractyl Health (GUTS) United States $0.079B 0.00
Corbus Pharmaceuticals Holdings (CRBP) United States $0.079B 0.00
ESSA Pharma (EPIX) Canada $0.076B 0.00
Telomir Pharmaceuticals (TELO) United States $0.074B 0.00
Context Therapeutics (CNTX) United States $0.070B 0.00
Unicycive Therapeutics (UNCY) United States $0.066B 0.00
Pyxis Oncology (PYXS) United States $0.066B 0.00
Inotiv (NOTV) United States $0.066B 0.00
Cumberland Pharmaceuticals (CPIX) United States $0.066B 52.22
Nutriband (NTRB) United States $0.064B 0.00
Vivani Medical (VANI) United States $0.062B 0.00
Allergy Therapeutics (AGYTF) United Kingdom $0.059B 0.00
Assertio Holdings (ASRT) United States $0.058B 0.00
Gain Therapeutics (GANX) United States $0.057B 0.00
Metagenomi (MGX) United States $0.056B 0.00
Karyopharm Therapeutics (KPTI) United States $0.052B 0.00
Century Therapeutics (IPSC) United States $0.046B 0.00
PMV Pharmaceuticals (PMVP) United States $0.046B 0.00
Mural Oncology (MURA) Ireland $0.045B 0.00
Avalo Therapeutics (AVTX) United States $0.044B 0.00
Verrica Pharmaceuticals (VRCA) United States $0.041B 0.00
Reviva Pharmaceuticals Holdings (RVPH) United States $0.038B 0.00
SCYNEXIS (SCYX) United States $0.037B 0.00
Iterum Therapeutics (ITRM) Ireland $0.036B 0.00
Acrivon Therapeutics (ACRV) United States $0.036B 0.00
Rafael Holdings (RFL) United States $0.036B 0.00
NRx Pharmaceuticals (NRXP) United States $0.035B 0.00
ElectroCore (ECOR) United States $0.035B 0.00
Prelude Therapeutics (PRLD) United States $0.034B 0.00
FibroGen (FGEN) United States $0.031B 0.00
PolyPid (PYPD) Israel $0.028B 0.00
Surrozen (SRZN) United States $0.027B 0.00
Enlivex Therapeutics (ENLV) Israel $0.024B 0.00
Tempest Therapeutics (TPST) United States $0.024B 0.00
CASI Pharmaceuticals (CASI) China $0.023B 0.00
DURECT (DRRX) United States $0.023B 0.00
Mannatech (MTEX) United States $0.021B 8.31
BioVie (BIVI) United States $0.021B 0.00
Jupiter Neurosciences (JUNS) United States $0.021B 0.00
Natural Alternatives (NAII) United States $0.020B 0.00
VYNE Therapeutics (VYNE) United States $0.020B 0.00
Vivos Therapeutics (VVOS) United States $0.018B 0.00
Lipocine (LPCN) United States $0.018B 0.00
TherapeuticsMD (TXMD) United States $0.017B 0.00
GlycoMimetics (GLYC) United States $0.016B 0.00
Relmada Therapeutics (RLMD) United States $0.014B 0.00
MARKER THERAPEUTICS, INC (MRKR) United States $0.013B 0.00
ProPhase Labs (PRPH) United States $0.013B 0.00
Ernexa Therapeutics (ERNA) United States $0.012B 0.00
Scienture Holdings (SCNX) United States $0.012B 0.00
Cosmos Health (COSM) United States $0.011B 0.00
Minerva Neurosciences (NERV) United States $0.011B 8.47
Plus Therapeutics (PSTV) United States $0.011B 0.00
Talphera (TLPH) United States $0.011B 0.00
BioLineRx (BLRX) Israel $0.011B 0.00
Kiora Pharmaceuticals (KPRX) United States $0.010B 0.00
Biomerica (BMRA) United States $0.009B 0.00
Mangoceuticals (MGRX) United States $0.009B 0.00
Addex Therapeutics (ADXN) Switzerland $0.009B 0.00
Phio Pharmaceuticals (PHIO) United States $0.008B 0.00
Ainos (AIMD) United States $0.008B 0.00
TransCode Therapeutics (RNAZ) United States $0.008B 0.00
Carisma Therapeutics (CARM) United States $0.008B 0.00
Nuvilex (PMCB) United States $0.008B 0.00
Citius Pharmaceuticals (CTXR) United States $0.007B 0.00
Traws Pharma (TRAW) United States $0.007B 0.00
XTL Biopharmaceuticals (XTLB) Israel $0.007B 0.00
Lyra Therapeutics (LYRA) United States $0.007B 0.00
Indaptus Therapeutics (INDP) United States $0.006B 0.00
NLS Pharmaceutics (NLSP) Switzerland $0.006B 0.00
Jaguar Animal Health (JAGX) United States $0.006B 0.00
Sonoma Pharmaceuticals (SNOA) United States $0.005B 0.00
Xenetic Biosciences (XBIO) United States $0.005B 0.00
Alaunos Therapeutics (TCRT) United States $0.005B 0.00
Klotho Neurosciences (KLTO) United States $0.005B 0.00
Aptorum Group (APM) United Kingdom $0.005B 0.00
Conduit Pharmaceuticals (CDT) United States $0.005B 0.00
Clearmind Medicine (CMND) Canada $0.004B 0.00
XORTX Therapeutics (XRTX) Canada $0.004B 0.00
SciSparc (SPRC) Israel $0.004B 0.00
Quoin Pharmaceuticals (QNRX) United States $0.004B 0.00
Redhill Biopharma (RDHL) Israel $0.004B 0.00
60 Degrees Pharmaceuticals (SXTP) United States $0.004B 0.00
PainReform (PRFX) Israel $0.004B 0.00
CERo Therapeutics Holdings (CERO) United States $0.004B 0.00
InMed Pharmaceuticals (INM) Canada $0.003B 0.00
Qualigen Therapeutics (QLGN) United States $0.003B 0.00
Galmed Pharmaceuticals (GLMD) Israel $0.002B 0.00
Incannex Healthcare (IXHL) Australia $0.002B 0.00
TNF Pharmaceuticals (TNFA) United States $0.002B 0.00
Salarius Pharmaceuticals (SLRX) United States $0.002B 0.00
SHINECO (SISI) China $0.001B 0.00
Shuttle Pharmaceuticals Holdings (SHPH) United States $0.001B 0.00
China SXT Pharmaceuticals (SXTC) China $0.001B 0.00
Heatwurx (PCSA) United States $0.001B 0.00
Petros Pharmaceuticals (PTPI) United States $0.000B 0.00
Universe Pharmaceuticals INC (UPC) China $0.000B 0.00
Aditxt (ADTX) United States $0.000B 0.00
4D Pharma (LBPS) United Kingdom $0.000B 0.00
MEI Pharma (MEIP) United States $0.000B 0.00
Patheon (PTHN) Netherlands $0.000B 0.00
RVL Pharmaceuticals (RVLP) United States $0.000B 0.00
Silence Therapeutics (SLN) United Kingdom $0.000B 0.00